The E3 Ubiquitin-Ligase Bmi1/Ring1A Controls the Proteasomal Degradation of Top2α Cleavage Complex – A Potentially New Drug Target

• Iris Alchanati,

  Affiliation Proteologics Ltd, Rehovot, Israel

  ⨯
• Carmit Teicher,

  Affiliation Proteologics Ltd, Rehovot, Israel

  ⨯
• Galit Cohen,

  Affiliation Proteologics Ltd, Rehovot, Israel

  ⨯
• Vivian Shemesh,

  Affiliation Proteologics Ltd, Rehovot, Israel

  ⨯
• Haim M. Barr,

  Affiliation Proteologics Ltd, Rehovot, Israel

  ⨯
• Philippe Nakache,

  Affiliation Proteologics Ltd, Rehovot, Israel

  ⨯
• Danny Ben-Avraham,

  Affiliation Proteologics Ltd, Rehovot, Israel

  ⨯
• Anna Idelevich,

  Affiliation Proteologics Ltd, Rehovot, Israel

  ⨯
• Itzchak Angel,

  Affiliation Proteologics Ltd, Rehovot, Israel

  ⨯
• Nurit Livnah,

  Affiliation Proteologics Ltd, Rehovot, Israel

  ⨯
• Shmuel Tuvia,

  Affiliation Proteologics Ltd, Rehovot, Israel

  ⨯
• Yuval Reiss,

  Affiliation Proteologics Ltd, Rehovot, Israel

  ⨯
• Daniel Taglicht,

  Affiliation Proteologics Ltd, Rehovot, Israel

  ⨯
• Omri Erez

  * E-mail: omri@proteologics.com

  Affiliation Proteologics Ltd, Rehovot, Israel

  ⨯